Cost-effectiveness of gene therapy for sickle cell disease in Uganda: tailoring high-income evidence to Uganda’s context
Fields of Study & Subjects
Hemoglobinopathies and Related Disorders
Biomedical Ethics and Regulation
CRISPR and Genetic Engineering
Publication details
- Journal / source
- Gene Therapy
- Publisher
- Springer Science and Business Media LLC
- Volume
- 33
- Issue
- 2
- Pages
- 109–117
- Publication date
- 26 February 2026
- Language
- EN